Related Experiment Videos
Potential mechanisms for chemotherapy-induced impairments in cognitive function
Catherine Jansen1, Christine Miaskowski, Marilyn Dodd
1Kaiser Permanente Medical Center in San Francisco, University of California, USA. catherine.jansen@kp.org
Oncology Nursing Forum
|November 5, 2005
Summary
Chemotherapy can cause cognitive impairments through various mechanisms, even if it does not cross the blood-brain barrier. Identifying high-risk patients is crucial for informed consent and preventive strategies.
Area of Science:
- Neuroscience
- Oncology
- Pharmacology
Background:
- Cognitive function relies on complex neuroanatomic structures.
- Chemotherapeutic agents are widely used in cancer treatment.
- Chemotherapy-induced cognitive impairment (CICI) is a growing concern.
Purpose of the Study:
- Review cognitive function domains and neuroanatomy.
- Present evidence of neurotoxicity from chemotherapeutic agents.
- Explore potential mechanisms of CICI.
Main Methods:
- Literature review of published research articles.
- Inclusion of review articles and textbooks.
- Synthesis of current evidence on neurotoxicity and CICI.
Main Results:
- Chemotherapy generally does not cross the blood-brain barrier at standard doses.
- Multiple mechanisms can contribute to CICI.
- Patient-specific factors influence risk and protection against CICI.
Conclusions:
- Evidence for CICI exists, but mechanisms remain unclear.
- Further research is needed to identify predictive factors and biomarkers.
- Identifying high-risk patients has implications for patient education and preventive care.